Chorus Limited/Announcement
Chorus Limited logo

Notification of issue of CIP securities

Capital Change5 May 2019CNUCommunication Services

Chorus Limited
Level 10, 1 Willis Street

P O Box 632

Wellington

New Zealand


Email: company.secretary@chorus.co.nz






STOCK EXCHANGE ANNOUNCEMENT


6 May 2019



Notification of issue of CIP securities


Chorus Limited has issued further Crown Infrastructure Partners (CIP) securities as

per the attached notices.






ENDS



For further information:


Brett Jackson

Investor Relations Manager

Phone: +64 4 896 4039

Mobile: +64 (27) 488 7808

Email: brett.jackson@chorus.co.nz

---

Capital Change Notice
Updated as at 28 January 2019

Page 1 of 2


Section 1: issuer information

Name of issuer Chorus Limited

NZX ticker code CNU

Class of Financial Product CIP1 Warrants (unquoted)

ISIN N/a

Section 2: capital change details

Number issued/acquired/redeemed/ 190,559 CIP1 Warrants (unquoted).

Nominal value (if any) N/a.

Issue/acquisition/redemption/ price Nil per CIP1 Warrant.

Nature of the payment (for example,

cash or other consideration)

N/a.

Amount paid up (if not in full) N/a.

Percentage of total class of Financial

Products issued/acquired/redeemed/

(calculated on the number of Financial

Products of the Class, excluding any

Treasury Stock, in existence)

1.61% CIP1 Warrants

For an issue of Convertible Financial

Products or Options, the principal terms

of Conversion (for example the

Conversion price and Conversion date

and the ranking of the Financial Product

in relation to other Classes of Financial

Product) or the Option (for example, the

exercise price and exercise date)


CIP1 Warrants are an option to acquire ordinary

Chorus shares on a specified exercise date at a set

strike price.


CIP1 Warrants are issued for no consideration with

each tranche of CIP1 Equity Securities.


Each CIP1 Warrant gives the holder the right, on a

specified exercise date, to purchase an ordinary

Chorus share at a set strike price. The strike price is

based on a total shareholder return of 16% per

annum on ordinary Chorus shares over the relevant

period. Therefore, a holder of a CIP1 Warrant is only

likely to exercise the CIP1 Warrant if total

shareholder return on ordinary Chorus shares has

exceeded 16% per annum over that period.


The exercise dates correspond to the repayment

dates for the CIP1 Debt Securities and the dates on

which dividends become payable on an increased

proportion of CIP1 Equity Securities, and will

therefore be between 2025 and 2036.


Further information regarding the terms of the CIP1

Warrants is set out in the summary of CIP1 Securities

Page 2 of 2

which is available at

https://company.chorus.co.nz/reports.

Reason for issue/acquisition/redemption

and specific authority for

issue/acquisition/redemption/ (the

reason for change must be identified

here)

The CIP1 Warrants have been issued pursuant to:


 the terms of the subscription agreement

between Chorus and CIP dated 9 November

2011, as amended by agreements between

Chorus and CIP dated 18 September 2016

and 26 January 2017 (UFB1 Subscription

Agreement); and

 a Chorus Board resolution passed on 3 April

2012.

Total number of Financial Products of

the Class after the

issue/acquisition/redemption/Conversio

n (excluding Treasury Stock) and the

total number of Financial Products of

the Class held as Treasury Stock after

the issue/acquisition/redemption.

11,997,671 CIP1 Warrants (unquoted)

No CIP1 Warrants are held as treasury stock.

In the case of an acquisition of shares,

whether those shares are to be held as

treasury stock

N/a.

Specific authority for the issue,

acquisition, or redemption, including a

reference to the rule pursuant to which

the issue, acquisition, or redemption is

made

Board resolution passed on 3 April 2012.


The CIP1 Warrants have been issued under listing

rule 4.2 pursuant to a waiver dated 30 November

2011.

Terms or details of the issue,

acquisition, or redemption (for example:

restrictions, escrow arrangements)

The terms of issue are as set out in the UFB1

Subscription Agreement. Further information

regarding the terms of the CIP1 Warrants is set out in

the summary of CIP1 Securities which is available at

https://company.chorus.co.nz/reports.

Date of issue/acquisition/redemption 3 May 2019

Section 3: authority for this announcement

Name of person authorised to make this

announcement

Elaine Campbell

General Counsel & Company Secretary

Contact phone number +64 9 975 2983

Contact email address Elaine.Campbell@chorus.co.nz

Date of release via MAP 6 May 2019

---

Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B


New issue announcement,

application for quotation of additional securities

and agreement


Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12,

04/03/13



Name of entity

Chorus Limited (“Chorus”)


ABN

152 485 848


We (the entity) give ASX the following information.



Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).


1

+

Class of

+

securities issued or to

be issued


CIP1 Warrants




2

Number of

+

securities issued or

to be issued (if known) or

maximum number which may be

issued


190,559 CIP1 Warrants





3

Principal terms of the

+

securities

(e.g. if options, exercise price and

expiry date; if partly paid

+

securities, the amount

outstanding and due dates for

payment; if

+

convertible

securities, the conversion price

and dates for conversion)

The CIP1 Warrants are an option to acquire ordinary

shares in Chorus on a specified exercise date at a set strike

price.


The terms of issue for the CIP1 Warrants are as set out in

the subscription agreement between Chorus and Crown

Infrastructure Partners Limited (CIP) dated 9 November

2011 as amended by agreements between Chorus and CIP

dated 18 September 2016 and 26 January 2017 (UFB1

Subscription Agreement). Further details are set out in

the summary of CIP1 Securities which is available at

https://company.chorus.co.nz/reports


4
Do the

+

securities rank equally in

all respects from the

+

issue date

with an existing

+

class of quoted

+

securities?


If the additional

+

securities do

not rank equally, please state:

 the date from which they do

 the extent to which they

participate for the next

dividend, (in the case of a

trust, distribution) or interest

payment

 the extent to which they do

not rank equally, other than

in relation to the next

dividend, distribution or

interest payment

N/a



5 Issue price or consideration


Nil per CIP1 Warrants



6 Purpose of the issue

(If issued as consideration for the

acquisition of assets, clearly

identify those assets)

Adjustment pursuant to the terms of the UFB1

Subscription Agreement




6a

Is the entity an

+

eligible entity

that has obtained security holder

approval under rule 7.1A?


If Yes, complete sections 6b – 6h

in relation to the

+

securities the

subject of this Appendix 3B, and

comply with section 6i

N/a



6b The date the security holder

resolution under rule 7.1A was

passed

N/a



6c

Number of

+

securities issued

without security holder approval

under rule 7.1

N/a



6d

Number of

+

securities issued

with security holder approval

under rule 7.1A

N/a


6e
Number of

+

securities issued

with security holder approval

under rule 7.3, or another

specific security holder approval

(specify date of meeting)


N/a



6f

Number of

+

securities issued

under an exception in rule 7.2

N/a



6g

If

+

securities issued under rule

7.1A, was issue price at least 75%

of 15 day VWAP as calculated

under rule 7.1A.3? Include the

+

issue date and both values.

Include the source of the VWAP

calculation.

N/a



6h

If

+

securities were issued under

rule 7.1A for non-cash

consideration, state date on

which valuation of consideration

was released to ASX Market

Announcements

N/a



6i Calculate the entity’s remaining

issue capacity under rule 7.1 and

rule 7.1A – complete Annexure 1

and release to ASX Market

Announcements

N/a



7

+

Issue dates

Note: The issue date may be prescribed by ASX

(refer to the definition of issue date in rule

19.12). For example, the issue date for a pro rata

entitlement issue must comply with the

applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

3 May 2019




Number

+

Class

8

Number and

+

class of all

+

securities quoted on ASX

(including the

+

securities in

section 2 if applicable)




439,288,154


500,000,000

Fully paid ordinary shares


Euro Medium Term Notes



Number:

+

Class

9

Number and

+

class of all

+

securities not quoted on ASX

(including the

+

securities in

section 2 if applicable)

407,320,381



407,320,381



11,997,671



43,385,038

CIP1 Equity Securities

(unquoted)


CIP1 Debt Securities

(unquoted)


CIP1 Warrants (unquoted)


CIP2 Equity Securities

(unquoted)



10 Dividend policy (in the case of a

trust, distribution policy) on the

increased capital (interests)

N/a



Part 2 - Pro rata issue


11 Is security holder approval

required?


N/a



12 Is the issue renounceable or non-

renounceable?

N/a



13

Ratio in which the

+

securities will

be offered

N/a



14

+

Class of

+

securities to which the

offer relates

N/a



15

+

Record date to determine

entitlements

N/a



16 Will holdings on different

registers (or subregisters) be

aggregated for calculating

entitlements?

N/a



17 Policy for deciding entitlements

in relation to fractions


N/a



18 Names of countries in which the

entity has security holders who

will not be sent new offer

documents

Note: Security holders must be told how their

entitlements are to be dealt with.

Cross reference: rule 7.7.

N/a


19 Closing date for receipt of
acceptances or renunciations

N/a








20 Names of any underwriters


N/a



21 Amount of any underwriting fee

or commission

N/a



22 Names of any brokers to the issue

N/a



23 Fee or commission payable to the

broker to the issue

N/a



24 Amount of any handling fee

payable to brokers who lodge

acceptances or renunciations on

behalf of security holders

N/a



25 If the issue is contingent on

security holders’ approval, the

date of the meeting

N/a



26 Date entitlement and acceptance

form and offer documents will be

sent to persons entitled

N/a



27 If the entity has issued options,

and the terms entitle option

holders to participate on exercise,

the date on which notices will be

sent to option holders

N/a



28 Date rights trading will begin (if

applicable)

N/a



29 Date rights trading will end (if

applicable)



N/a



30 How do security holders sell their

entitlements in full through a

broker?

N/a



31 How do security holders sell part

of their entitlements through a

broker and accept for the

balance?

N/a



32 How do security holders dispose
of their entitlements (except by

sale through a broker)?

N/a



33

+

Issue date



N/a


Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities


34

Type of

+

securities

(tick one)


(a)


+

Securities described in Part 1



(b)


All other

+

securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,

employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible

securities


Entities that have ticked box 34(a)


Additional securities forming a new class of securities



Tick to indicate you are providing the information or

documents



35


If the

+

securities are

+

equity securities, the names of the 20 largest holders of the

additional

+

securities, and the number and percentage of additional

+

securities

held by those holders



36


If the

+

securities are

+

equity securities, a distribution schedule of the additional

+

securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over



37


A copy of any trust deed for the additional

+

securities



Entities that have ticked box 34(b)


38

Number of

+

securities for which

+

quotation is sought





39
+

Class of

+

securities for which

quotation is sought





40

Do the

+

securities rank equally in

all respects from the

+

issue date

with an existing

+

class of quoted

+

securities?


If the additional

+

securities do not

rank equally, please state:

 the date from which they do

 the extent to which they

participate for the next

dividend, (in the case of a trust,

distribution) or interest

payment

 the extent to which they do not

rank equally, other than in

relation to the next dividend,

distribution or interest

payment




41 Reason for request for quotation

now

Example: In the case of restricted securities, end

of restriction period


(if issued upon conversion of

another

+

security, clearly identify

that other

+

security)






Number

+

Class

42

Number and

+

class of all

+

securities quoted on ASX

(including the

+

securities in clause

38)







+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 8

Quotation agreement


1

+

Quotation of our additional

+

securities is in ASX’s absolute discretion. ASX may quote

the

+

securities on any conditions it decides.


2 We warrant the following to ASX.


 The issue of the

+

securities to be quoted complies with the law and is not for an

illegal purpose.


 There is no reason why those

+

securities should not be granted

+

quotation.


 An offer of the

+

securities for sale within 12 months after their issue will not

require disclosure under section 707(3) or section 1012C(6) of the Corporations

Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this

warranty


 Section 724 or section 1016E of the Corporations Act does not apply to any

applications received by us in relation to any

+

securities to be quoted and that

no-one has any right to return any

+

securities to be quoted under sections 737,

738 or 1016F of the Corporations Act at the time that we request that the

+

securities be quoted.


 If we are a trust, we warrant that no person has the right to return the

+

securities

to be quoted under section 1019B of the Corporations Act at the time that we

request that the

+

securities be quoted.


3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim,

action or expense arising from or connected with any breach of the warranties in this

agreement.


4 We give ASX the information and documents required by this form. If any information

or document is not available now, we will give it to ASX before

+

quotation of the

+

securities begins. We acknowledge that ASX is relying on the information and

documents. We warrant that they are (will be) true and complete.




Sign here: ......................................................... Date: 03 May 2019

(Director/Company Secretary)


Print name: Elaine Campbell


== == == == ==

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.